Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Intangibles (2016 - 2025)

Historic Intangibles for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $138.2 million.

  • Usana Health Sciences' Intangibles rose 37254.85% to $138.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.2 million, marking a year-over-year increase of 37254.85%. This contributed to the annual value of $151.8 million for FY2024, which is 40744.68% up from last year.
  • According to the latest figures from Q3 2025, Usana Health Sciences' Intangibles is $138.2 million, which was up 37254.85% from $142.7 million recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' Intangibles peaked at $151.8 million during Q4 2024, and registered a low of $28.6 million during Q2 2024.
  • Moreover, its 5-year median value for Intangibles was $30.5 million (2021), whereas its average is $54.0 million.
  • Per our database at Business Quant, Usana Health Sciences' Intangibles tumbled by 2566.78% in 2022 and then soared by 40744.68% in 2024.
  • Usana Health Sciences' Intangibles (Quarter) stood at $30.3 million in 2021, then grew by 6.99% to $32.4 million in 2022, then dropped by 7.75% to $29.9 million in 2023, then soared by 407.45% to $151.8 million in 2024, then fell by 9.0% to $138.2 million in 2025.
  • Its last three reported values are $138.2 million in Q3 2025, $142.7 million for Q2 2025, and $147.2 million during Q1 2025.